Rani Therapeutics Holdings, Inc. (RANI) Tops Q1 EPS by 15c

Rani Therapeutics Holdings, Inc. (NASDAQ: RANI) reported Q1 EPS of ($0.33), $0.15 better than the analyst estimate of ($0.48).

For earnings history and earnings-related data on Rani Therapeutics Holdings, Inc. (RANI) click here.

You May Also Be Interested In

• BofA raises AMD target to $720, sees server CPU TAM tripling to $211B by 2030
• KeyBanc gets bearish on Comcast as broadband competition intensifies
• BMS Zenbexus doubles response rates in myeloma trial